Status:
COMPLETED
Telemedicine in Patients with Type 1 Diabetes Mellitus.
Lead Sponsor:
Consorci Sanitari de l'Alt Penedès i Garraf
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Management of patients with type 1 Diabetes Mellitus has been changing rapidly in recent years, due in part to the introduction of new technologies such as Apps that recommend insulin boluses, or the ...
Detailed Description
Classic management of patients with type 1 diabetes (T1D) by endocrinologists consisted of carrying out a visit every 3-6 months in which HbA1c, microalbuminuria and a notebook with a variable number ...
Eligibility Criteria
Inclusion
- Patients with T1D over 18 years of age
- Duration of T1D greater than 6 months
- Access to smartphones
- In those patients with CGM, the minimum time for handling the sensor before randomization will be 2 months.
Exclusion
- Inability to handle smartphones or Apps to manage T1D.
- Admission due to acute decompensation of TD1 in previous 3 months, presence of more than one severe monthly hypoglycemia, or any other circumstance that requires frequent visits and intensive diabetes education
- Inability to sign the informed consent
Key Trial Info
Start Date :
January 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04758884
Start Date
January 9 2021
End Date
February 2 2022
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Comarcal de l'Alt Penedès
Vilafranca del Penedès, Barcelona, Spain, 08720